These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1490663)

  • 21. [Recombinant human growth hormone treatment in short children with renal disease--our first experience].
    Spasojević-Dimitrijeva B; Kostić M; Peco-Antić A; Kruscić D; Cvetković M; Milosevski-Lomić G; Paripović D
    Srp Arh Celok Lek; 2010; 138(3-4):197-203. PubMed ID: 20499500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a recombinant human growth hormone preparation on the urinary 15nitrogen balance in growth-hormone-deficient children.
    Zachmann M; Kempken B; Frisch H; Fiser I
    Horm Res; 1988; 29(4):140-2. PubMed ID: 3220455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of growth response to rhGH in short children before and after renal transplantation. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Wühl E; Haffner D; Tönshoff B; Mehls O
    Kidney Int Suppl; 1993 Oct; 43():S76-82. PubMed ID: 8246375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth response to recombinant human growth hormone of mammalian cell origin in prepubertal growth hormone-deficient children during the first two years of treatment.
    Stubbe P; Frasier SD; Stahnke N; Cacciari E; Job JC; Preece M; Frisch H; Zachmann M; Zeisel HJ
    Horm Res; 1992; 37 Suppl 2():28-36. PubMed ID: 1490665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
    Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.
    Zavras N; Meazza C; Pilotta A; Gertosio C; Pagani S; Tinelli C; Bozzola M
    Ital J Pediatr; 2015 Oct; 41():71. PubMed ID: 26444854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.
    Hou L; Chen ZH; Liu D; Cheng YG; Luo XP
    Drug Des Devel Ther; 2016; 10():13-21. PubMed ID: 26719670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology.
    Bérard E; André JL; Guest G; Berthier F; Afanetti M; Cochat P; Broyer M;
    Pediatr Nephrol; 2008 Nov; 23(11):2031-8. PubMed ID: 18584215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
    Tagliaferri M; Scacchi M; Pincelli AI; Berselli ME; Silvestri P; Montesano A; Ortolani S; Dubini A; Cavagnini F
    Int J Obes Relat Metab Disord; 1998 Sep; 22(9):836-41. PubMed ID: 9756240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age.
    Cutfield WS; Jackson WE; Jefferies C; Robinson EM; Breier BH; Richards GE; Hofman PL
    J Pediatr; 2003 Feb; 142(2):113-6. PubMed ID: 12584529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linear growth response to recombinant human growth hormone in children with growth hormone deficiency.
    Shih KC; Ho LT; Kuo HF; Chang TC; Liu PC; Chen CK; Tiu CM
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jul; 54(1):7-13. PubMed ID: 8087727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
    Costalonga EF; Antonini SR; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15N tracer techniques for the differential diagnosis of dwarfism and prediction of growth hormone action in children.
    Richter I; Heine W; Plath C; Mix M; Wutzke KD; Töwe J
    J Clin Endocrinol Metab; 1987 Jul; 65(1):74-7. PubMed ID: 3584400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved cumulated nitrogen balance after administration of recombinant human growth hormone in patients undergoing gastrointestinal surgery.
    Tacke J; Bolder U; Löhlein D
    Infusionsther Transfusionsmed; 1994 Feb; 21(1):24-9. PubMed ID: 8173309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of growth hormone on growth and blood urea levels in children with chronic renal failure.
    McMahon KA; Powell HR; Walker RG; Jones CL
    J Paediatr Child Health; 1994 Jun; 30(3):230-3. PubMed ID: 8074908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
    Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
    Costalonga EF; Antonini SR; Guerra G; Coletta RR; Franca MM; Braz AF; Mendonca BB; Arnhold IJ; Jorge AA
    Pharmacogenomics J; 2012 Oct; 12(5):439-45. PubMed ID: 21468024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.